rs370883583

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_021098.3(CACNA1H):​c.6199G>A​(p.Val2067Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000136 in 1,495,404 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V2067A) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000079 ( 0 hom., cov: 35)
Exomes 𝑓: 0.00014 ( 0 hom. )

Consequence

CACNA1H
NM_021098.3 missense

Scores

2
16

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:2

Conservation

PhyloP100: -3.85

Publications

1 publications found
Variant links:
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
  • hyperaldosteronism, familial, type IV
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • childhood absence epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • epilepsy, childhood absence, susceptibility to, 6
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • epilepsy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.028915316).
BP6
Variant 16-1220131-G-A is Benign according to our data. Variant chr16-1220131-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 529574.
BS2
High AC in GnomAd4 at 12 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_021098.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1H
NM_021098.3
MANE Select
c.6199G>Ap.Val2067Ile
missense
Exon 35 of 35NP_066921.2O95180-1
CACNA1H
NM_001005407.2
c.6181G>Ap.Val2061Ile
missense
Exon 34 of 34NP_001005407.1O95180-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1H
ENST00000348261.11
TSL:1 MANE Select
c.6199G>Ap.Val2067Ile
missense
Exon 35 of 35ENSP00000334198.7O95180-1
CACNA1H
ENST00000569107.6
TSL:1
c.6214G>Ap.Val2072Ile
missense
Exon 34 of 34ENSP00000454990.2H3BNT0
CACNA1H
ENST00000711493.1
c.6184G>Ap.Val2062Ile
missense
Exon 34 of 34ENSP00000518778.1A0AAA9YHG8

Frequencies

GnomAD3 genomes
AF:
0.0000789
AC:
12
AN:
152184
Hom.:
0
Cov.:
35
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000132
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000680
AC:
10
AN:
147110
AF XY:
0.0000618
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000978
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000125
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000142
AC:
191
AN:
1343102
Hom.:
0
Cov.:
31
AF XY:
0.000131
AC XY:
86
AN XY:
658236
show subpopulations
African (AFR)
AF:
0.0000366
AC:
1
AN:
27336
American (AMR)
AF:
0.00
AC:
0
AN:
29936
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
20400
East Asian (EAS)
AF:
0.0000886
AC:
3
AN:
33844
South Asian (SAS)
AF:
0.00
AC:
0
AN:
66664
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
48508
Middle Eastern (MID)
AF:
0.000187
AC:
1
AN:
5336
European-Non Finnish (NFE)
AF:
0.000166
AC:
175
AN:
1055804
Other (OTH)
AF:
0.000199
AC:
11
AN:
55274
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
11
22
32
43
54
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000788
AC:
12
AN:
152302
Hom.:
0
Cov.:
35
AF XY:
0.0000537
AC XY:
4
AN XY:
74466
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41566
American (AMR)
AF:
0.0000653
AC:
1
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5172
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000132
AC:
9
AN:
68016
Other (OTH)
AF:
0.00
AC:
0
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000215
Hom.:
0
Bravo
AF:
0.0000680
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000242
AC:
2
ExAC
AF:
0.0000586
AC:
7

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Epilepsy, childhood absence, susceptibility to, 6;C4310756:Hyperaldosteronism, familial, type IV (1)
-
-
1
Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV (1)
-
1
-
Inborn genetic diseases (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.067
BayesDel_addAF
Benign
-0.30
T
BayesDel_noAF
Benign
-0.35
CADD
Benign
0.017
DANN
Benign
0.89
DEOGEN2
Benign
0.12
T
Eigen
Benign
-1.8
Eigen_PC
Benign
-2.0
FATHMM_MKL
Benign
0.065
N
LIST_S2
Benign
0.51
T
M_CAP
Uncertain
0.091
D
MetaRNN
Benign
0.029
T
MetaSVM
Uncertain
0.046
D
MutationAssessor
Benign
0.62
N
PhyloP100
-3.9
PrimateAI
Benign
0.37
T
PROVEAN
Benign
-0.26
N
REVEL
Benign
0.21
Sift
Benign
0.48
T
Sift4G
Benign
0.26
T
Polyphen
0.0030
B
Vest4
0.027
MVP
0.61
ClinPred
0.038
T
GERP RS
-8.3
Varity_R
0.042
gMVP
0.14
Mutation Taster
=91/9
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs370883583; hg19: chr16-1270131; COSMIC: COSV52352781; COSMIC: COSV52352781; API